Patents by Inventor Aaron Cooper

Aaron Cooper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12262792
    Abstract: Footwear or other foot-receiving devices include various conforming fit, stability, and/or “locked down” feel features. The uppers (or foot-covering components) for such articles of footwear (or other foot-receiving devices) may include one or more of: (a) an upper shell defining an interior chamber, wherein the upper shell includes a plantar support surface and sidewalls extending from an outer perimeter of the plantar support surface; (b) a bootie component (e.g., formed as a sock or sock-like garment) received in the interior chamber; (c) one or more foot wrapping bands; and/or (d) an interior midsole within the bootie component. The bootie component and/or the foot wrapping band(s) may be secured to the upper shell at a location inside an outer perimeter of the plantar support surface of the upper shell and beyond the bight line between the sidewalls of the upper and the plantar support surface.
    Type: Grant
    Filed: April 28, 2023
    Date of Patent: April 1, 2025
    Assignee: NIKE, Inc.
    Inventor: Aaron Cooper
  • Publication number: 20250084492
    Abstract: Described herein are methods useful for detecting and diagnosing pathogen infection using PCR and sequencing.
    Type: Application
    Filed: September 13, 2024
    Publication date: March 13, 2025
    Inventors: Sriram KOSURI, Eric Matthew JONES, Aaron COOPER, Molly Jeanette GASPERINI
  • Publication number: 20250084273
    Abstract: A coatings system for improved scratch resistance is provided. The coatings system comprises: 1) a primer comprising a difunctional (meth)acrylate ester monomer, a first multifunctional (meth)acrylate, and a first silane-treated aluminum oxide; and 2) a topcoat comprising a difunctional (meth)acrylate ester monomer, a second multifunctional (meth)acrylate, and a second silane-treated aluminum oxide. Further, the coatings system may be UV curable or another type of radiation curable. A method of preparing the coatings system and an article coated with the coatings system are also described.
    Type: Application
    Filed: September 12, 2024
    Publication date: March 13, 2025
    Inventors: Bradley J. WINKLE, Christopher BERLINGHOF, Aaron COOPER, Randolph G. COX, Jigarkumar B. PATEL, Kyle PATMORE, Christine BOPP, Brian L. BROWN
  • Publication number: 20250049854
    Abstract: Provided herein are systems comprising one or both of cytokines and/or synthetic pathway activators. Also provided herein are systems comprising one or more suppressors of gene expression, and one or both of cytokines and/or synthetic pathway activators. Also provided are systems of chimeric priming receptors that bind ALPG and/or ALPP, chimeric antigen receptors that bind MSLN, and at least one of one or more suppressors of gene expression, and/or one or both of cytokines and/or synthetic pathway activators; cells expressing such systems; and methods of use thereof.
    Type: Application
    Filed: October 17, 2024
    Publication date: February 13, 2025
    Inventors: Aaron Cooper, Joseph Choe, Sofia Kyriazopoulou Panagiotopoulou, Marian Sandoval, Gavin Shavey, Stephen Santoro, Luke Cassereau, Brian Hsu, Jason Hall, Natalie Bezman, Thomas Gardner, Anzhi Yao
  • Patent number: 12171323
    Abstract: A pouch or pocket may act as a container and may be used to securely hold objects (e.g., cell phone, keys, wallet, etc.) during athletic activity (e.g., running). The pouch may be a standalone item or integrally formed as part of other items. The pouch may hold the object to be stored in place within the pouch or pocket. The pouch may provide some cushioning or impact force attenuation to protect the object being held within the pouch or pocket. Additionally, the pouch may be attached to a garment, such as running clothes. The pouch includes an outer envelope sealable by a closure and a one-way valve with foam layers located inside the pouch. After the object is placed in the pouch, the closure is closed, and the air within the pouch is expelled via the one-way valve by compressing the foam layers from the outside.
    Type: Grant
    Filed: August 2, 2023
    Date of Patent: December 24, 2024
    Assignee: NIKE, Inc.
    Inventors: Aaron Cooper, Austin Orand, Nadia M. Panian, Peter P. Williams, II
  • Patent number: 12129523
    Abstract: Described herein are methods useful for detecting and diagnosing pathogen infection using PCR and sequencing.
    Type: Grant
    Filed: April 5, 2021
    Date of Patent: October 29, 2024
    Assignee: Octant, Inc.
    Inventors: Sriram Kosuri, Eric Matthew Jones, Aaron Cooper, Molly Jeanette Gasperini
  • Publication number: 20240342348
    Abstract: A medical device may be coated with a therapeutic composition that includes a direct oral anticoagulant. An illustrative drug coating composition may comprise an excipient including polylactic acid (PLA), poly(lactic-co-glycolic acid) (PLGA), or poly(vinylidene fluoride)-co-hexafluoropropylene (PVDF-HFP) and a direct oral anticoagulant (DOAC). The illustrative drug coating may be applied to an outer surface of a medical device.
    Type: Application
    Filed: April 11, 2024
    Publication date: October 17, 2024
    Applicant: Boston Scientific Scimed, Inc.
    Inventors: Thomas John Herbst, Edward Kopesky, Steven L. Kangas, Hongxia Zeng, Aaron Cooper Foss
  • Publication number: 20240342346
    Abstract: A medical device may be coated with a therapeutic composition that includes everolimus. Everolimus crystals may be coated with a mixture of excipients to form encapsulated everolimus crystals suspended in a coating composition. An illustrative coating composition may comprise a mixture of excipients including a bioresorbable or thermo-gelling polymer and a plasticizing agent and a therapeutic agent. The bioresorbable or thermo-gelling polymer may be selected from polycaprolactone (PCL) or poloxamer.
    Type: Application
    Filed: April 11, 2024
    Publication date: October 17, 2024
    Applicant: Boston Scientific Scimed, Inc.
    Inventors: Andrew J. Ro, Nicholas Michael Job, Aaron Cooper Foss, Amanda Maxwell
  • Publication number: 20240307594
    Abstract: A medical device may be coated with a therapeutic composition that includes everolimus. Everolimus crystals may be coated with a mixture of excipients to form encapsulated everolimus crystals suspended in a coating composition. The medical device may be contacted with the coating composition in order to form a coating on the medical device. Coating the everolimus crystals with a mixture of excipients to form encapsulated everolimus crystals suspended in a coating composition may include suspending everolimus crystals in a first solution that includes acetyl tri-butyl citrate (ATBC) and adding a second solution to the first solution, the second solution including ethyl cellulose (EC), the EC mixing with the ATBC and coating the everolimus crystals, thereby forming a coating suspension including coated everolimus crystals in the suspension.
    Type: Application
    Filed: March 15, 2024
    Publication date: September 19, 2024
    Applicant: Boston Scientific Scimed, Inc.
    Inventors: Jonathan Pascal Chaky, Ryan Lee Reifsteck, Aaron Cooper Foss, Nicholas Michael Job
  • Publication number: 20240309106
    Abstract: Provided herein are recombinant nucleic acids encoding chimeric priming receptors that bind ALPG/P, chimeric antigen receptors that bind MSLN, and shRNA that target FAS, PTPN2, and/or TOX. Also provided are systems of chimeric priming receptors that bind ALPG/P, chimeric antigen receptors that bind MSLN, and shRNA that target FAS, PTPN2, and/or TOX, cells expressing such proteins and shRNA, and methods of use thereof.
    Type: Application
    Filed: May 29, 2024
    Publication date: September 19, 2024
    Inventors: Jasper Williams, Michelle Nguyen, Anzhi Yao, Stephen Santoro, Aaron Cooper, John Gagnon, Adam Litterman, Omar Khan, Natalie Bezman, Katherine Harris, Harbani Kaur Malik Chaudhry, Nicole Allen
  • Publication number: 20240268806
    Abstract: Systems, devices, and methods for closing a large bore access site are disclosed. An example system may include a delivery catheter and a closure device releasably coupled to the delivery catheter. The closure device may include an expandable frame and a patch secured to the expandable frame. The closure device may be configured to shift between a delivery configuration and an expanded configuration. The closure device may be configured to be delivered by the delivery catheter through a blood vessel to a position adjacent to a large bore opening formed in the blood vessel while in the delivery configuration and then shifted to the expanded configuration within the blood vessel so that the patch engages and covers the large bore opening.
    Type: Application
    Filed: February 14, 2023
    Publication date: August 15, 2024
    Applicant: Boston Scientific Scimed Inc.
    Inventors: Gary John Pederson, JR., Michael Nagel, Andrew Roiko, Aaron Cooper Foss
  • Publication number: 20240240164
    Abstract: Provided herein are compositions and methods for producing genetically engineered cells, such as T cells, with an insertion of a cassette at a designated genomic locus. Methods of using the genetically engineered cells for treating or preventing a disease in a subject are also provided.
    Type: Application
    Filed: October 13, 2023
    Publication date: July 18, 2024
    Inventors: Aaron Cooper, Pei-Ken Hsu, Robert Moot, Annie Truong, Thomas Gardner, Brian Hsu
  • Patent number: 12037407
    Abstract: Provided herein are recombinant nucleic acids encoding chimeric priming receptors that bind ALPG/P, chimeric antigen receptors that bind MSLN, and shRNA that target FAS, PTPN2, and/or TOX. Also provided are systems of chimeric priming receptors that bind ALPG/P, chimeric antigen receptors that bind MSLN, and shRNA that target FAS, PTPN2, and/or TOX, cells expressing such proteins and shRNA, and methods of use thereof.
    Type: Grant
    Filed: May 3, 2023
    Date of Patent: July 16, 2024
    Assignee: Arsenal Biosciences, Inc.
    Inventors: Jasper Williams, Michelle Nguyen, Anzhi Yao, Stephen Santoro, Aaron Cooper, John Gagnon, Adam Litterman, Omar Khan, Natalie Bezman, Katherine Harris, Harbani Kaur Malik Chaudhry, Nicole Allen
  • Publication number: 20240230643
    Abstract: Described herein are systems for measuring enzymatic activities. Also described herein are methods for measuring or screening enzymatic activities utilizing the systems described herein.
    Type: Application
    Filed: February 1, 2022
    Publication date: July 11, 2024
    Inventors: Henry CHAN, Aaron COOPER, Molly Jeanette GASPERINI
  • Publication number: 20240132934
    Abstract: Described herein are systems for measuring enzymatic activities. Also described herein are methods for measuring or screening enzymatic activities utilizing the systems described herein.
    Type: Application
    Filed: February 1, 2022
    Publication date: April 25, 2024
    Inventors: Henry CHAN, Aaron COOPER, Molly Jeanette GASPERINI
  • Publication number: 20240112170
    Abstract: Various methods are provided for facilitating access to linked information to GPS or short-range wireless equipped devices. One example method may comprise receiving, via a network, an indication of an interaction between a primary device and a third-party device, the indication comprising at least a first element and a second element, the first element indicative of user identification information and the second element indicative of at least one of a location or a bounded region, determining, as a function of at least the first element and the second element, a data object that upon validation is configured for use a subsequent interaction, and transmitting, to a mobile device, an electronic communication comprising an indication, configured for rendering on the mobile device, of the data object.
    Type: Application
    Filed: October 9, 2023
    Publication date: April 4, 2024
    Inventors: Rajat Shroff, Aaron Cooper, Elton Cheung, Tyler Renaghan, James J. Sullivan
  • Publication number: 20230416747
    Abstract: Provided herein are safe harbor loci and methods for identifying and using safe harbor loci to engineer cells to express transgenes. The safe harbor loci exhibit increased transgene knock-in efficiency and allow for increased, stable expression of transgenes in engineered cells. Guide ribonucleic acids (gRNAs) may be used for insertion of transgenes in the safe harbor loci.
    Type: Application
    Filed: August 22, 2023
    Publication date: December 28, 2023
    Inventors: Xinying Zheng, Brendan Galvin, Somya Khare, Aaron Cooper, Michelle Nguyen, Anzhi Yao
  • Publication number: 20230371678
    Abstract: A pouch or pocket may act as a container and may be used to securely hold objects (e.g., cell phone, keys, wallet, etc.) during athletic activity (e.g., running). The pouch may be a standalone item or integrally formed as part of other items. The pouch may hold the object to be stored in place within the pouch or pocket. The pouch may provide some cushioning or impact force attenuation to protect the object being held within the pouch or pocket. Additionally, the pouch may be attached to a garment, such as running clothes. The pouch includes an outer envelope sealable by a closure and a one-way valve with foam layers located inside the pouch. After the object is placed in the pouch, the closure is closed, and the air within the pouch is expelled via the one-way valve by compressing the foam layers from the outside.
    Type: Application
    Filed: August 2, 2023
    Publication date: November 23, 2023
    Applicant: NIKE, Inc.
    Inventors: Aaron Cooper, Austin Orand, Nadia M. Panian, Peter P. Williams, II
  • Publication number: 20230365997
    Abstract: Provided herein are compositions and methods for producing genomically edited cells expressing an exogenous transgene and restored or continued expression of an endogenous gene. Methods of using the genomically edited cells for treating or preventing a disease in a subject are also provided.
    Type: Application
    Filed: April 27, 2023
    Publication date: November 16, 2023
    Inventors: Aaron Cooper, Angela Boroughs, Pei-Ken Hsu
  • Patent number: 11816653
    Abstract: Various methods are provided for facilitating access to linked information to GPS or short-range wireless equipped devices. One example method may comprise receiving, via a network, an indication of an interaction between a primary device and a third-party device, the indication comprising at least a first element and a second element, the first element indicative of user identification information and the second element indicative of at least one of a location or a bounded region, determining, as a function of at least the first element and the second element, a data object that upon validation is configured for use a subsequent interaction, and transmitting, to a mobile device, an electronic communication comprising an indication, configured for rendering on the mobile device, of the data object.
    Type: Grant
    Filed: December 19, 2017
    Date of Patent: November 14, 2023
    Assignee: GROUPON, INC.
    Inventors: Rajat Shroff, Aaron Cooper, Elton Cheung, Tyler Renaghan, James J. Sullivan